XML 53 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Entities and Acquisitions - La Jolla Pharmaceutical Company (Details) - La Jolla Pharmaceutical Company - USD ($)
$ / shares in Units, $ in Millions
6 Months Ended 12 Months Ended
Aug. 22, 2022
Jun. 30, 2023
Dec. 31, 2022
CONSOLIDATED ENTITIES      
Measurement period adjustments for change in value of goodwill   $ 13.1  
Decrease in deferred tax liabilities   2.6  
Increase in deferred tax assets   $ 10.5  
Total consideration paid $ 206.6    
Acquisition share price $ 6.23    
Acquisition-related costs     $ 5.3